x None
Entity Type
0001059784
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 GENEREX BIOTECHNOLOGY CORP
Jurisdiction of Incorporation/Organization
DELAWARE
 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed  



2. Principal Place of Business and Contact Information
Name of Issuer  
 GENEREX BIOTECHNOLOGY CORP  
Street Address 1 Street Address 2
 10102 USA TODAY WAY  
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
 MIRAMAR  FLORIDA  33025  416-364-2551 



3. Related Persons
Last Name First Name Middle Name
Moscato Joseph
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  CEO, President, and Chairman of the Board

Last Name First Name Middle Name
Ro Andrew
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  Chief Investment Officer and Director

Last Name First Name Middle Name
Corrao Mark
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  Chief Financial Officer and Treasurer

Last Name First Name Middle Name
Thompson Terry
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  Chief Operating Officer

 
Last Name First Name Middle Name
Crisci Anthony
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  Chief Legal Officer

Last Name First Name Middle Name
Purcell Richard
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  Executive Vice President of Research & Drug Development

Last Name First Name Middle Name
Terrell Jason
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  Chief Scientific Officer

Last Name First Name Middle Name
Eagle Craig
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  Independent Director

 
Last Name First Name Middle Name
McGee Brian
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  Independent Director

Last Name First Name Middle Name
Anderson James
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  Independent Director

Last Name First Name Middle Name
Salvo Lawrence
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  Independent Director

Last Name First Name Middle Name
Prioletti Mark
Street Address 1 Street Address 2
10102 USA Today Way
City State/Province/Country ZIP/Postal Code
Miramar FLORIDA 33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  Independent Director

 


4. Industry Group
o Agriculture   Health Care o Retailing
  Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance   Technology
  o Insurance   o Hospitals & Physicians   o Computers
  o Investing   x Pharmaceuticals   o Telecommunications
  o Investment Banking   o Other Health Care   o Other Technology
  o Pooled Investment Fund

        Travel
  o Other Banking & Financial Services o Manufacturing   o Airlines & Airports
  Real Estate   o Lodging & Conventions
  o Commercial   o Tourism & Travel Services
  o Construction   o Other Travel
  o REITS & Finance o Other
  o Residential  
  o Other Real Estate  
o Business Services  
  Energy  
  o Coal Mining  
  o Electric Utilities  
  o Energy Conservation  
  o Environmental Services  
  o Oil & Gas  
  o Other Energy  


5. Issuer Size
Revenue Range Aggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale  2020-08-04 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
   


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary)  
  

11. Minimum Investment
Minimum investment accepted from any outside investor $ 0 USD

12. Sales Compensation
Recipient Recipient CRD Number o None
 Dawson James Securities, Inc  130645
(Associated) Broker or Dealer x None (Associated) Broker or Dealer CRD Number x None
     
Street Address 1 Street Address 2
 1 N. Federal Highway 5th Floor   
City State/Province/Country ZIP/Postal Code
 Boca Raton  FLORIDA  33432
State(s) of Solicitation o All States o Foreign/Non-US
 FLORIDA
 NEW YORK
 

 



13. Offering and Sales Amounts
Total Offering Amount $   USD x Indefinite
Total Amount Sold $ 2000000 USD  
Total Remaining to be Sold $   USD x Indefinite
 
Clarification of Response (if Necessary)
 Common shares of the company's common stock and warrants were issued in a private placement, as disclosed on the issuer's Current Report on Form 8-K, filed with the SEC on August 7, 2020.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 3


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions $ 80000 USD o Estimate
Finders' Fees $ 0 USD o Estimate
 
Clarification of Response (if Necessary)
 Represents a Placement Agent Fee payable to Dawson James Securities, Inc.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
  $ 0 USD o
Generex Biotechnology (QB) (USOTC:GNBT)
Historical Stock Chart
From Oct 2020 to Oct 2020 Click Here for more Generex Biotechnology (QB) Charts.
Generex Biotechnology (QB) (USOTC:GNBT)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Generex Biotechnology (QB) Charts.